I'll answer the questions in two parts. With respect to the acute incidents and the mitigation measures, yes, the sooner we can get those technologies in place, the better.
However, we are re-evaluating all the neonicotinoids. That is requiring the chemical companies to generate a significant amount of additional data, much of which is going to be Canadian specific or at least relevant to Canada so we can evaluate the broader issue with the neonicotinoids. There's a short-term framework in terms of dealing with the acute issues, then the longer-term issue in terms of neonicotinoids as a whole. As I said, we're monitoring the information as it's being developed. If anything comes to light that would require regulatory action, we wouldn't hesitate to take it.